Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 109

1.

Apoptosis induced by piroxicam plus cisplatin combined treatment is triggered by p21 in mesothelioma.

Baldi A, Piccolo MT, Boccellino MR, Donizetti A, Cardillo I, La Porta R, Quagliuolo L, Spugnini EP, Cordero F, Citro G, Menegozzo M, Calogero RA, Crispi S.

PLoS One. 2011;6(8):e23569. doi: 10.1371/journal.pone.0023569. Epub 2011 Aug 17.

PMID:
21858171
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Molecular analysis of the effects of Piroxicam and Cisplatin on mesothelioma cells growth and viability.

Verdina A, Cardillo I, Nebbioso A, Galati R, Menegozzo S, Altucci L, Sacchi A, Baldi A.

J Transl Med. 2008 May 22;6:27. doi: 10.1186/1479-5876-6-27.

PMID:
18498639
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Piroxicam and cisplatin in a mouse model of peritoneal mesothelioma.

Spugnini EP, Cardillo I, Verdina A, Crispi S, Saviozzi S, Calogero R, Nebbioso A, Altucci L, Cortese G, Galati R, Chien J, Shridhar V, Vincenzi B, Citro G, Cognetti F, Sacchi A, Baldi A.

Clin Cancer Res. 2006 Oct 15;12(20 Pt 1):6133-43.

PMID:
17062690
[PubMed - indexed for MEDLINE]
Free Article
4.

Targeted proteasome inhibition by Velcade induces apoptosis in human mesothelioma and breast cancer cell lines.

Wang Y, Rishi AK, Puliyappadamba VT, Sharma S, Yang H, Tarca A, Dou QP, Lonardo F, Ruckdeschel JC, Pass HI, Wali A.

Cancer Chemother Pharmacol. 2010 Aug;66(3):455-66. doi: 10.1007/s00280-009-1181-8. Epub 2009 Dec 4.

PMID:
19960346
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Valproate, in combination with pemetrexed and cisplatin, provides additional efficacy to the treatment of malignant mesothelioma.

Vandermeers F, Hubert P, Delvenne P, Mascaux C, Grigoriu B, Burny A, Scherpereel A, Willems L.

Clin Cancer Res. 2009 Apr 15;15(8):2818-28. doi: 10.1158/1078-0432.CCR-08-1579. Epub 2009 Apr 7.

PMID:
19351772
[PubMed - indexed for MEDLINE]
Free Article
6.

Extracellular signal-regulated kinase 5: a potential therapeutic target for malignant mesotheliomas.

Shukla A, Miller JM, Cason C, Sayan M, MacPherson MB, Beuschel SL, Hillegass J, Vacek PM, Pass HI, Mossman BT.

Clin Cancer Res. 2013 Apr 15;19(8):2071-83. doi: 10.1158/1078-0432.CCR-12-3202. Epub 2013 Feb 27.

PMID:
23446998
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

IRF-1 expression is induced by cisplatin in ovarian cancer cells and limits drug effectiveness.

Pavan S, Olivero M, Corà D, Di Renzo MF.

Eur J Cancer. 2013 Mar;49(4):964-73. doi: 10.1016/j.ejca.2012.09.024. Epub 2012 Oct 15.

PMID:
23079474
[PubMed - indexed for MEDLINE]
8.

A dual role of p21waf1/cip1 gene in apoptosis of HEp-2 treated with cisplatin or methotrexate.

Kraljevic Pavelic S, Cacev T, Kralj M.

Cancer Gene Ther. 2008 Sep;15(9):576-90. doi: 10.1038/cgt.2008.28. Epub 2008 May 16.

PMID:
18483502
[PubMed - indexed for MEDLINE]
9.

In vitro and in vivo therapeutic efficacy of the PPAR-γ agonist troglitazone in combination with cisplatin against malignant pleural mesothelioma cell growth.

Hamaguchi N, Hamada H, Miyoshi S, Irifune K, Ito R, Miyazaki T, Higaki J.

Cancer Sci. 2010 Sep;101(9):1955-64. doi: 10.1111/j.1349-7006.2010.01632.x.

PMID:
20608936
[PubMed - indexed for MEDLINE]
10.

Effects of the cyclooxygenase inhibitor, piroxicam, in combination with chemotherapy on tumor response, apoptosis, and angiogenesis in a canine model of human invasive urinary bladder cancer.

Mohammed SI, Craig BA, Mutsaers AJ, Glickman NW, Snyder PW, deGortari AE, Schlittler DL, Coffman KT, Bonney PL, Knapp DW.

Mol Cancer Ther. 2003 Feb;2(2):183-8.

PMID:
12589035
[PubMed - indexed for MEDLINE]
Free Article
11.

Antisense oligonucleotides directed at the bcl-xl gene product augment chemotherapy response in mesothelioma.

Ozvaran MK, Cao XX, Miller SD, Monia BA, Hong WK, Smythe WR.

Mol Cancer Ther. 2004 May;3(5):545-50.

PMID:
15141012
[PubMed - indexed for MEDLINE]
Free Article
12.

Aquaporin 3 (AQP3) participates in the cytotoxic response to nucleoside-derived drugs.

Trigueros-Motos L, Pérez-Torras S, Casado FJ, Molina-Arcas M, Pastor-Anglada M.

BMC Cancer. 2012 Sep 27;12:434. doi: 10.1186/1471-2407-12-434.

PMID:
23017148
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Antitumor effect of the histone deacetylase inhibitor LAQ824 in combination with 13-cis-retinoic acid in human malignant melanoma.

Kato Y, Salumbides BC, Wang XF, Qian DZ, Williams S, Wei Y, Sanni TB, Atadja P, Pili R.

Mol Cancer Ther. 2007 Jan;6(1):70-81.

PMID:
17237267
[PubMed - indexed for MEDLINE]
Free Article
14.

Apoptosis of bladder cancer by sodium butyrate and cisplatin.

Maruyama T, Yamamoto S, Qiu J, Ueda Y, Suzuki T, Nojima M, Shima H.

J Infect Chemother. 2012 Jun;18(3):288-95. doi: 10.1007/s10156-011-0322-2. Epub 2011 Oct 26.

PMID:
22041988
[PubMed - indexed for MEDLINE]
15.

P53-dependent antiproliferative and pro-apoptotic effects of trichostatin A (TSA) in glioblastoma cells.

Bajbouj K, Mawrin C, Hartig R, Schulze-Luehrmann J, Wilisch-Neumann A, Roessner A, Schneider-Stock R.

J Neurooncol. 2012 May;107(3):503-16. doi: 10.1007/s11060-011-0791-2. Epub 2012 Jan 20.

PMID:
22270849
[PubMed - indexed for MEDLINE]
16.

Differential regulation of p73 variants in response to cisplatin treatment in SH-SY5Y neuroblastoma cells.

Million K, Horvilleur E, Goldschneider D, Agina M, Raguénez G, Tournier F, Bénard J, Douc-Rasy S.

Int J Oncol. 2006 Jul;29(1):147-54.

PMID:
16773194
[PubMed - indexed for MEDLINE]
17.

The synergistic therapeutic effect of cisplatin with Human papillomavirus E6/E7 short interfering RNA on cervical cancer cell lines in vitro and in vivo.

Jung HS, Erkin OC, Kwon MJ, Kim SH, Jung JI, Oh YK, Her SW, Ju W, Choi YL, Song SY, Kim JK, Kim YD, Shim GY, Shin YK.

Int J Cancer. 2012 Apr 15;130(8):1925-36. doi: 10.1002/ijc.26197. Epub 2011 Aug 8.

PMID:
21630254
[PubMed - indexed for MEDLINE]
18.

New pyrazolo[3,4-d]pyrimidine SRC inhibitors induce apoptosis in mesothelioma cell lines through p27 nuclear stabilization.

Indovina P, Giorgi F, Rizzo V, Khadang B, Schenone S, Di Marzo D, Forte IM, Tomei V, Mattioli E, D'Urso V, Grilli B, Botta M, Giordano A, Pentimalli F.

Oncogene. 2012 Feb 16;31(7):929-38. doi: 10.1038/onc.2011.286. Epub 2011 Jul 25.

PMID:
21785466
[PubMed - indexed for MEDLINE]
19.

Downregulation of Bcl-xL and Mcl-1 is sufficient to induce cell death in mesothelioma cells highly refractory to conventional chemotherapy.

Varin E, Denoyelle C, Brotin E, Meryet-Figuière M, Giffard F, Abeilard E, Goux D, Gauduchon P, Icard P, Poulain L.

Carcinogenesis. 2010 Jun;31(6):984-93. doi: 10.1093/carcin/bgq026. Epub 2010 Feb 8.

PMID:
20142415
[PubMed - indexed for MEDLINE]
Free Article
20.

Preclinical studies of the proteasome inhibitor bortezomib in malignant pleural mesothelioma.

Gordon GJ, Mani M, Maulik G, Mukhopadhyay L, Yeap BY, Kindler HL, Salgia R, Sugarbaker DJ, Bueno R.

Cancer Chemother Pharmacol. 2008 Apr;61(4):549-58. Epub 2007 May 24.

PMID:
17522864
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk